Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next …
Arterial Remodeling Technologies reported from the podium yesterday at ‘TCT 2013’ that the Company has successfully completed the 30-day milestone portion of the “ARTDIVA” clinical trial of its novel bioresorbable stent.
Remodeling – Yahoo News Search Results
Short URL: https://homeimprovementsdigest.com/?p=3393
Posted by henry
on Oct 29 2013. Filed under Remodeling.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
